Toggle navigation
TWunroll
TWunroll
faq
Contact US
#MedRxiv
Erin McCreary
ErinMcCreary
With the Jan 7th announcement of the @remap_cap IL-6ra results: https://www.medrxiv.org/content/10.1101/2021.01.07.21249390v2 and last nights @BMJ_Latest RCT drop: https://www.bmj.com/content/372/bmj.n84let’s talk about tocilizumab [threa
Read more
Jacob Gudiol
JacobGudiol
Idag är det minst 30 personer som smittas av coronaviruset som kommer att dö inom en månadOch det sannolikt en ganska ordentlig underskattninglåg mig förklara Det är egentligen ganska enkel
Read more
Derrick VanGennep
VanGennepD
A thread on "long covid", which describes long-term symptoms of Covid-19. My point here is that infections matter, not just deaths.https://www.youtube.com/watch?v=reHPBedlPxU An in-depth interview with someone suffering long-covid
Read more
Josh - Data Analyst in Nashville
ifihadastick
THREAD: Are Schools SAFE during Covid? A Collection of Research, Science, and Data on Schools: Risks to children, teachers, and comparisons within the community.Sources: Academic, institutional or governmental. I will
Read more
Bloom Lab
jbloom_lab
We mapped how all mutations to #SARSCoV2 receptor-binding domain (RBD) affect recognition by convalescent polyclonal human sera (https://biorxiv.org/content/10.1101/2020.12.31.425021v1).Among implications: E484K (South African lineage) worr
Read more
ɪᴀɴ ᴍ. ᴍᴀᴄᴋᴀʏ, ᴘʜᴅ 🦠🤧🧬🥼🦟🧻
MackayIM
"can you link to evidence that the virus was isolated" is becoming fake moon landing level stupid Study1: 23JAN2020https://www.biorxiv.org/content/10.1101/2020.01.22.914952v2bronchoalveolar lavage fluid from RT-PCR-positive patien
Read more
Kulvinder Kaur MD
dockaurG
Pls read #SARSCoV2 immunology& subthreads for what media & “experts” are not telling youFacts-we have some pre-existing cross-protective immunity-basing herd immunity only on antibodies omits strong Tcell immunity-vaccine candid
Read more
Trevor Bedford
trvrb
With emerging variants of SARS-CoV-2 and initial evidence of antigenic evolution, I've seen comparisons here to seasonal influenza and its rate of evolution. In this thread, I want to ground
Read more
The Sharing Scientist
ScienceShared
The important thing to note with operation moonshot is that, realistically, it’s not going to be ready in time to even potentially prevent another second wave. Is it just another
Read more
Anup Malani
anup_malani
I'm excited to see our Karnataka sero-prevalence study out in @JAMA_current today. This is part of a longer chain of surveys we've done to track and understand COVID in India
Read more
Hannah Davis 🦈
ahandvanish
Yay our #LongCovid paper is online!!!https://www.medrxiv.org/content/10.1101/2020.12.24.20248802v2While we had a few thousand more fill in the survey, this paper focuses on 3,762 #longhaulers (sick >28 days) who got sick between Dec-May
Read more
COVID Impact
CovidSerology
Manaus has now surpassed the very tragic 26/04 burial record of 167 with 198 burials in the past 24H (13/01) for a total of 1486 burials in January with 50%
Read more
Atomsk's Sanakan
AtomsksSanakan
1/Many COVID-19 contrarians, including those behind the Great Barrington Declaration, *still* cite John Ioannidis' inaccurate estimate of SARS-CoV-2's fatality rate.So let's go over how atrocious Ioannidis' paper is.https://
Read more
Florian Krammer
florian_krammer
1) So, this morning I promised a little tweetorial about variants and here we go. This will be from a vaccine/antibody point of view only, I won't comment on how
Read more
A Marm Kilpatrick
DiseaseEcology
Viral loads (& age but not symptoms) influences transmission probability, incubation period & symptomatic/asymptomatic outcome.Fantastic new study @dr_michaelmarks. Tons to learn & haven't seen any detailed thread yet, so he
Read more
Carl T. Bergstrom
CT_Bergstrom
1. Thread: Model-based mitigation strategies for school reopening. I will start with a disclosure. The work described was done in collaboration with @Color Health and I was paid as a
Read more
‹
1
2
...
22
23
24
25
26
27
28
...
31
32
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree